Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1998-12-22
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
47 576, 47 58, 504100, 544 67, A01N 4388
Patent
active
058520120
ABSTRACT:
Compounds of the formula ##STR1## in which A is an unsubstituted or mono- to tetrasubstituted, aromatic or non-aromatic, monocyclic or bicyclic heterocyclic radical, where one to two of the substituents of A can be selected from the group consisting of halo-C.sub.1 -C.sub.3 alkyl, cyclopropyl, halocyclopropyl, C.sub.2 -C.sub.3 alkenyl, C.sub.2 -C.sub.3 alkynyl, halo-C.sub.2 -C.sub.3 alkenyl, halo-C.sub.2 -C.sub.3 alkynyl, halo-C.sub.1 -C.sub.3 alkoxy, C.sub.1 -C.sub.3 alkylthio, halo-C.sub.1 -C.sub.3 alkylthio, allyloxy, propargyloxy, allylthio, propargylthio, haloallyloxy, haloallylthio, cyano and nitro, and one to four of the substituents of A can be selected from the group consisting of C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy and halogen;
REFERENCES:
patent: 4742056 (1988-05-01), Farooq et al.
patent: 4803277 (1989-02-01), Shiokawa et al.
patent: 4849432 (1989-07-01), Shiokawa et al.
patent: 4880933 (1989-11-01), Shiokawa et al.
patent: 5032589 (1991-07-01), Shiokawa et al.
patent: 5034404 (1991-07-01), Uneme et al.
patent: 5034524 (1991-07-01), Shiokawa et al.
patent: 5051434 (1991-09-01), Kozo et al.
patent: 5719146 (1998-02-01), Shiokawa et al.
Takimoto et al., Bull. Chem. Soc. Jpn., 56, pp. 3319-3322 (1983).
Shiba et al., Bull. Chem. Soc. Jpn., 62, pp. 3721-3723 (1989).
Yu et al., Chem. Abstracts 111:157006q (1989).
Yu et al, Propellante, Explosives, Pyrotechnics 14, pp. 150-152 (1989).
Gsell Laurenz
Maienfisch Peter
Mathias Marla J.
Novartis Corporation
Raymond Richard L.
Teoli, Jr. William A.
LandOfFree
Oxadiazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxadiazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxadiazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2047878